Omega Operating Cycle from 2010 to 2026

OHI Stock  USD 47.40  0.36  0.77%   
Omega Healthcare's Operating Cycle is increasing with stable movements from year to year. Operating Cycle is predicted to flatten to 306.74. For the period between 2010 and 2026, Omega Healthcare, Operating Cycle quarterly trend regression had mean deviation of  153.77 and range of 968. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
609.16573672
Current Value
306.74
Quarterly Volatility
214.21077626
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Omega Healthcare financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omega Healthcare's main balance sheet or income statement drivers, such as Depreciation And Amortization of 341.5 M, Interest Expense of 231.6 M or Selling General Administrative of 29 M, as well as many indicators such as Price To Sales Ratio of 5.67, Dividend Yield of 0.1 or PTB Ratio of 1.3. Omega financial statements analysis is a perfect complement when working with Omega Healthcare Valuation or Volatility modules.
  
Build AI portfolio with Omega Stock
Check out the analysis of Omega Healthcare Correlation against competitors.
The Operating Cycle trend for Omega Healthcare Investors offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Omega Healthcare is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Omega Healthcare's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Omega Healthcare Investors over the last few years. It is Omega Healthcare's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Omega Healthcare's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Pretty Stable
   Operating Cycle   
       Timeline  

Omega Operating Cycle Regression Statistics

Arithmetic Mean547.59
Geometric Mean446.37
Coefficient Of Variation39.12
Mean Deviation153.77
Median542.25
Standard Deviation214.21
Sample Variance45,886
Range968
R-Value0.15
Mean Square Error47,872
R-Squared0.02
Significance0.57
Slope6.28
Total Sum of Squares734,180

Omega Operating Cycle History

2026 306.74
2025 609.17
2024 705.41
2023 662.19
2022 607.84
2021 542.25
2020 466.75

About Omega Healthcare Financial Statements

Investors use fundamental indicators, such as Omega Healthcare's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Omega Healthcare's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 609.17  306.74 

Currently Active Assets on Macroaxis

When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:
Check out the analysis of Omega Healthcare Correlation against competitors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is there potential for Diversified REITs market expansion? Will Omega introduce new products? Factors like these will boost the valuation of Omega Healthcare. Anticipated expansion of Omega directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about Omega Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.346
Dividend Share
2.68
Earnings Share
1.94
Revenue Per Share
4.081
Quarterly Revenue Growth
0.143
The market value of Omega Healthcare Inv is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Omega Healthcare's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Omega Healthcare's market value can be influenced by many factors that don't directly affect Omega Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Omega Healthcare's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Omega Healthcare should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Omega Healthcare's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.